although physostigmine produced marked glycogenolysis in the control dogs it significantly inhibited cardiac glycogenolysis after light petroleum plus adrenaline , atrial glycogenolysis after strophanthin-k-induced arrhythmias and ventricular glycogenolysis after myocardial ischaemia.5 .
C0018787
cardiac
C0018827
ventricular